首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Characterization in rat aorta of the binding sites responsible for blockade of noradrenaline-evoked calcium entry by nisoldipine.
【2h】

Characterization in rat aorta of the binding sites responsible for blockade of noradrenaline-evoked calcium entry by nisoldipine.

机译:在大鼠主动脉中的结合位点表征了尼索地平阻断去甲肾上腺素诱发的钙进入。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. The effectiveness of the calcium antagonist, 1,4-dihydropyridine nisoldipine, as an inhibitor of contraction and 45Ca entry evoked by noradrenaline in rat aorta has been investigated and correlated with binding characteristics in intact artery. 2. Contractions evoked by noradrenaline were concentration-dependently depressed by nisoldipine (0.3-300 nM). About 60% of the response was resistant to inhibition, while KCl-induced contractions could be completely blocked. Noradrenaline-induced contractions were also less sensitive to nisoldipine inhibition than were KCl-induced contractions. 3. Preincubation of the aorta with nisoldipine in high KCl depolarizing solution increased the inhibition of the contraction evoked by a short application of noradrenaline or KCl to a similar extent. 4. The inhibition by nisoldipine of 45Ca influx evoked either by KCl depolarizing solution or by noradrenaline correlated well with the inhibition of the contractile responses. However, while KCl-stimulated 45Ca influx was totally abolished by nisoldipine (300 nM), 38% of the noradrenaline-stimulated 45Ca influx was resistant to inhibition by nisoldipine (300 nM). 5. The study of [3H]-(+)-PN 200-10 ([3H]-(+)-isradipine) binding in intact aorta showed the presence of a homogeneous population of specific binding sites. KD values were dependent on the KCl concentration in the bath while Bmax was unaffected. Binding of [3H]-(+)-isradipine was also increased in tissue exposed to noradrenaline; in the presence of 10(-5) M noradrenaline, binding parameters of [3H]-(+)-isradipine were close to the values obtained in aorta bathed in 20 mM KCl solution. 6. Displacement of [3H]-(+)-isradipine specific binding by nisoldipine was determined in segments of mesenteric artery and of aorta. The potency of nisoldipine was dependent on the incubation conditions applied to the vessel, as follows: KCl (100 mM) depolarizing solution greater than noradrenaline (10(-5) M) = KCl (25 mM) solution greater than physiological solution. The Ki value measured in aorta exposed to noradrenaline (10(-5) M) was close to the IC50 value of nisoldipine on the noradrenaline-evoked contraction. 7. The membrane potential value of rat aorta was estimated by the distribution of [3H]-tetraphenylphosphonium bromide ([3H]-TPP+), [3H]-TPP+ uptake concentration-dependently decreased when the KCl concentration in the bath was increased from 5.9 to 130 mM. Noradrenaline also concentration-dependently decreased [3H]-TPP+ uptake; the maximum effect (1-10 microns noradrenaline) was comparable in amplitude to the effect of 25 mM KCl solution.(ABSTRACT TRUNCATED AT 400 WORDS)
机译:1.已经研究了钙拮抗剂1,4-二氢吡啶尼索地平作为去甲肾上腺素在大鼠主动脉中引起的收缩和45Ca进入抑制剂的作用,并与完整动脉的结合特性相关。 2.去甲肾上腺素引起的收缩被尼索地平(0.3-300 nM)浓度依赖性抑制。约60%的反应对抑制有抵抗力,而KCl诱导的收缩可被完全阻断。去甲肾上腺素诱导的收缩对尼索地平抑制的敏感性也比氯化钾诱导的收缩低。 3.在高KCl去极化溶液中用尼索地平对主动脉进行预温育,以类似程度的短暂应用去甲肾上腺素或KCl可以增强对收缩的抑制作用。 4.尼索地平对氯化钾去极化溶液或去甲肾上腺素引起的45Ca流入的抑制作用与抑制收缩反应密切相关。但是,尼索地平(300 nM)完全消除了KCl刺激的45Ca内流,但去甲肾上腺素刺激的45Ca内流中有38%对尼索地平(300 nM)的抑制有抵抗力。 5. [3H]-(+)-PN 200-10([3H]-(+)-异拉地平)在完整主动脉中的结合研究表明,存在均匀结合的特异性结合位点。 KD值取决于浴液中KCl的浓度,而Bmax不受影响。在暴露于去甲肾上腺素的组织中,[3H]-(+)-伊拉地平的结合也增加了。在存在10(-5)M去甲肾上腺素的情况下,[3H]-(+)-伊拉地平的结合参数接近于沐浴在20 mM KCl溶液中的主动脉中获得的值。 6.测定了尼索地平在肠系膜动脉和主动脉段中[3H]-(+)-异拉地平特异性结合的置换。尼索地平的效力取决于应用于容器的孵育条件,如下所示:大于去甲肾上腺素(10(-5)M)的KCl(100 mM)去极化溶液=大于生理学溶液的KCl(25 mM)溶液。在暴露于去甲肾上腺素(10(-5)M)的主动脉中测得的Ki值接近去甲肾上腺素引起的收缩时尼索地平的IC50值。 7.通过[3H]-四苯基溴化(([3H] -TPP +)的分布来估算大鼠主动脉的膜电位值,当浴液中的KCl浓度从5.9增加时,[3H] -TPP +的吸收浓度依赖地降低。至130 mM。去甲肾上腺素也浓度依赖性地降低了[3H] -TPP +的吸收。最大效果(去甲肾上腺素1-10微米)的幅度与25 mM KCl溶液的效果相当。(抽象截断为400字)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号